moderna

COVID-19 Novavax Vaccine Now Available for adolescents aged 12 – 17

Teens can register today to receive the COVID-19 Novavax vaccine! Following approvals from the Centers for Disease Control and Prevention (CDC) and the Texas Department of State Health Services (DSHS), Harris County Public Health (HCPH) is now offering the COVID-19 Novavax vaccine to adolescents aged 12 – 17. Novavax is a two-dose primary series given 3 weeks apart. Novavax uses a different technique than the other COVID-19 vaccines from Pfizer and Moderna. Instead of using […]

COVID-19 Novavax Vaccine Now Available at HCPH Sites

Residents can register today to receive the COVID-19 Novavax vaccine! Harris County Public Health (HCPH) is pleased to announce that there is a new option for people to get their COVID-19 vaccine. On July 13, 2022, the U.S. Food and Drug Administration (FDA) authorized the Novavax COVID-19 Vaccine for emergency use.  Following approvals of the Centers for Disease Control and Prevention (CDC) and Texas Department of State Health Services (DSHS), HCPH is now offering the […]

HCPH Now Administering Moderna COVID-19 Vaccines for Children 6 to 17 years old 

Residents ages 6 months and older can receive all doses of Moderna or Pfizer COVID-19 vaccines at any HCPH vaccination site Harris County Public Health (HCPH) is now administering the Moderna COVID-19 vaccine to children ages 6 to 17 years old. This follows the recent emergency use authorization given to both Pfizer and Moderna for children vaccinations ages 6 months to 5 years old by the U.S. Food and Drug Administration (FDA). HCPH encourages parents […]

Eligible Phase 1a Individuals To Receive Moderna COVID-19 Vaccine

Following the arrival of additional COVID-19 vaccines from the state, Harris County Public Health (HCPH) is now in the process of administering doses of the Moderna COVID-19 vaccine to eligible Phase 1a individuals. On December 23rd, the Texas Department of State Health Services (DSHS) delivered 3,000 doses to HCPH to support county efforts to vaccinate eligible recipients who may not already be served by the first round of the Pfizer vaccine. As part of this […]